The American Journal of Medicine
Volume 122, Issue 8 , Pages 778.e9-778.e15, August 2009

Depression and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease

  • Theodore A. Omachi, MD, MBA

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Corresponding Author InformationRequests for reprints should be addressed to Theodore A. Omachi, MD, MBA, Department of Medicine, University of California, San Francisco, Box 0111, 505 Parnassus Avenue, San Francisco, CA 94143-0111
  • ,
  • Patricia P. Katz, PhD

      Affiliations

    • Institute for Health Policy Studies, University of California, San Francisco
  • ,
  • Edward H. Yelin, PhD

      Affiliations

    • Institute for Health Policy Studies, University of California, San Francisco
    • Division of Rheumatology, Department of Medicine, University of California, San Francisco
  • ,
  • Steven E. Gregorich, PhD

      Affiliations

    • Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
  • ,
  • Carlos Iribarren, MD, MPH, PhD

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
  • ,
  • Paul D. Blanc, MD, MSPH

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco
  • ,
  • Mark D. Eisner, MD, MPH

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco

Abstract 

Background

Prior research on the risk of depression in chronic obstructive pulmonary disease (COPD) has yielded conflicting results. Furthermore, we have an incomplete understanding of how much depression versus respiratory factors contributes to poor health-related quality of life.

Methods

Among 1202 adults with COPD and 302 demographically matched referents without COPD, depressive symptoms were assessed using the 15-item Geriatric Depression Score. We measured COPD severity using a multifaceted approach, including spirometry, dyspnea, and exercise capacity. We used the Airway Questionnaire 20 and the Physical Component Summary Score to assess respiratory-specific and overall physical quality of life, respectively.

Results

In multivariate analysis adjusting for potential confounders including sociodemographics and all examined comorbidities, COPD subjects were at higher risk for depressive symptoms (Geriatric Depression Score ≥6) than referents (odds ratio [OR] 3.6; 95% confidence interval [CI], 2.1-6.1; P <.001). Stratifying COPD subjects by degree of obstruction on spirometry, all subgroups were at increased risk of depressive symptoms relative to referents (P <.001 for all). In multivariate analysis controlling for COPD severity as well as sociodemographics and comorbidities, depressive symptoms were strongly associated with worse respiratory-specific quality of life (OR 3.6; 95% CI, 2.7-4.8; P <.001) and worse overall physical quality of life (OR 2.4; 95% CI, 1.8-3.2; P <.001).

Conclusions

Patients with COPD are at significantly higher risk of having depressive symptoms than referents. Such symptoms are strongly associated with worse respiratory-specific and overall physical health-related quality of life, even after taking COPD severity into account.

Keywords: Chronic obstructive, Depression, Health status, Pulmonary disease, Quality of life

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding: Dr. Omachi was supported by the Agency for Healthcare Research and Quality, Grant number F32 HS017664. Dr. Eisner was supported by R01HL077618 from the National Heart, Lung, and Blood Institute, National Institutes of Health, and UCSF Bland Lane FAMRI Center of Excellence on Secondhand Smoke CoE2007.

 Conflict of Interest: None.

 Authorship: All authors had access to the data and a role in writing the manuscript.

PII: S0002-9343(09)00345-3

doi:10.1016/j.amjmed.2009.01.036

The American Journal of Medicine
Volume 122, Issue 8 , Pages 778.e9-778.e15, August 2009